DE602008002809D1 - Amorphes Aripiprazol und Verfahren zu seiner Herstellung - Google Patents

Amorphes Aripiprazol und Verfahren zu seiner Herstellung

Info

Publication number
DE602008002809D1
DE602008002809D1 DE602008002809T DE602008002809T DE602008002809D1 DE 602008002809 D1 DE602008002809 D1 DE 602008002809D1 DE 602008002809 T DE602008002809 T DE 602008002809T DE 602008002809 T DE602008002809 T DE 602008002809T DE 602008002809 D1 DE602008002809 D1 DE 602008002809D1
Authority
DE
Germany
Prior art keywords
preparation
amorphous aripiprazole
aripiprazole
amorphous
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008002809T
Other languages
English (en)
Inventor
Katja Dreyer
Uwe Loeffler
Klaus Glaenzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karl O Helm AG
Original Assignee
Karl O Helm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39529818&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602008002809(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Karl O Helm AG filed Critical Karl O Helm AG
Publication of DE602008002809D1 publication Critical patent/DE602008002809D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602008002809T 2008-01-23 2008-01-23 Amorphes Aripiprazol und Verfahren zu seiner Herstellung Active DE602008002809D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08150576A EP2082735B1 (de) 2008-01-23 2008-01-23 Amorphes Aripiprazol und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
DE602008002809D1 true DE602008002809D1 (de) 2010-11-11

Family

ID=39529818

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008002809T Active DE602008002809D1 (de) 2008-01-23 2008-01-23 Amorphes Aripiprazol und Verfahren zu seiner Herstellung

Country Status (6)

Country Link
EP (1) EP2082735B1 (de)
AT (1) ATE482691T1 (de)
DE (1) DE602008002809D1 (de)
ES (1) ES2353444T3 (de)
PL (1) PL2082735T3 (de)
PT (1) PT2082735E (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201000948A1 (tr) * 2010-02-09 2011-08-22 Sanovel İlaç San.Ve Ti̇c.A.Ş. Aripiprazol formülasyonları.
DE102010019416A1 (de) * 2010-05-04 2011-11-10 Stada Arzneimittel Ag Schmelztablette, umfassend ein Triptan oder ein atypisches Neuroleptikum
CN108078941A (zh) * 2018-02-07 2018-05-29 瑞阳制药有限公司 阿立哌唑口崩片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130587A (en) 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
JP4310605B2 (ja) 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
AU2003230192A1 (en) 2003-03-21 2004-10-11 Hetero Drugs Limited Novel crystalline forms of aripiprazole
EP1618103A2 (de) 2003-04-25 2006-01-25 Cadila Healthcare Ltd. Polymorphe von aripiprazol
WO2005009990A1 (en) 2003-07-25 2005-02-03 Hetero Drugs Limited Aripiprazole crystalline forms
PT1613598E (pt) 2003-12-16 2012-01-13 Teva Pharma Métodos para preparar formas cristalinas de aripiprazol
EP1880714A1 (de) * 2006-07-20 2008-01-23 Helm AG Amorphes Aripiprazol und Verfahren zu dessen Herstellung

Also Published As

Publication number Publication date
ATE482691T1 (de) 2010-10-15
EP2082735A1 (de) 2009-07-29
PT2082735E (pt) 2010-10-12
ES2353444T3 (es) 2011-03-02
PL2082735T3 (pl) 2011-05-31
EP2082735B1 (de) 2010-09-29

Similar Documents

Publication Publication Date Title
IL238438A (en) 2,2,2-trifluoroacetophenones and a method for preparing them
IL287311A (en) Antibodies and processes for their preparation
DE602006006654D1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
EP2151500A4 (de) Verzweigtes a-glucan, dieses produzierende a-glucosyltransferase, verfahren zur herstellung davon und verwendung davon
IL206148A0 (en) Polymeric composition, method for the manufacture of the polymeric composition, articles based on this polymeric composition and use of these articles
DE602006013001D1 (de) Zusammensetzung mit verbesserter stabilität und verfahren zu ihrer herstellung
DE102009037293A8 (de) Verbesserter Werkstückträger, Verfahren zu seiner Herstellung und dessen Verwendung
DE602006006597D1 (de) Durchlüftetes nahrungsmittel und verfahren zu seiner herstellung
EP2287267A4 (de) Zusammensetzung für ein schmutzabweisendes mittel, verfahren zur ihrer herstellung und damit behandelter artikel
ATE518847T1 (de) Verfahren zur herstellung von betamimetika
DE602007012474D1 (de) Multimodale polyethylenzusammensetzung, mischkatalysaotr und verfahren zur herstellung der zusammensetzung
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
ATE525123T1 (de) Vorrichtung zur herstellung von schokolade
ATE554088T1 (de) Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten
DE502006004187D1 (de) Verfahren zur herstellung von diorganopolysiloxanen
ATE437984T1 (de) Textiles flächengebilde, verfahren zur herstellung und verwendung
AT503967A3 (de) Vorrichtung zur herstellung von formteilen
EP2351613A4 (de) Katalysator, herstellungsverfahren dafür und seine verwendung
ATE445727T1 (de) Elastische einlage, verfahren zu deren herstellung und verwendung
DE602008005271D1 (de) Verfahren und vorrichtung zur herstellung von rauchartikeln
ATE473642T1 (de) Nahrungsmittel und verfahren zu seiner herstellung
ATE431868T1 (de) Verfahren zur herstellung laufmaschenfester textilien
DE502006002029D1 (de) Verfahren zur herstellung von polyetheraminen
DE602008002809D1 (de) Amorphes Aripiprazol und Verfahren zu seiner Herstellung
DE602006008329D1 (de) Verfahren zur herstellung von anilinen